| Product Code: ETC8539250 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Netherlands saw a significant shift in gemcitabine hydrochloride import patterns in 2024, with top exporters being the USA, Germany, China, South Korea, and Metropolitan France. This resulted in a notable increase in market concentration, as indicated by a substantial rise in the Herfindahl-Hirschman Index (HHI) from 2023 to 2024. The compound annual growth rate (CAGR) over the period 2020-2024 stood at 4.08%, while the growth rate from 2023 to 2024 was 3.72%, reflecting a steady expansion in the import market for gemcitabine hydrochloride in the Netherlands.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Gemcitabine Hydrochloride Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Gemcitabine Hydrochloride Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Gemcitabine Hydrochloride Market - Industry Life Cycle |
3.4 Netherlands Gemcitabine Hydrochloride Market - Porter's Five Forces |
3.5 Netherlands Gemcitabine Hydrochloride Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Netherlands Gemcitabine Hydrochloride Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Netherlands Gemcitabine Hydrochloride Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer in the Netherlands |
4.2.2 Growing demand for advanced chemotherapy treatments |
4.2.3 Technological advancements in drug delivery systems |
4.2.4 Favorable government initiatives and policies to improve healthcare infrastructure |
4.3 Market Restraints |
4.3.1 High cost associated with gemcitabine hydrochloride treatment |
4.3.2 Stringent regulatory requirements for drug approval |
4.3.3 Limited awareness about gemcitabine hydrochloride among patients and healthcare providers |
5 Netherlands Gemcitabine Hydrochloride Market Trends |
6 Netherlands Gemcitabine Hydrochloride Market, By Types |
6.1 Netherlands Gemcitabine Hydrochloride Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Gemcitabine Hydrochloride Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Netherlands Gemcitabine Hydrochloride Market Revenues & Volume, By Injection, 2021- 2031F |
6.1.4 Netherlands Gemcitabine Hydrochloride Market Revenues & Volume, By Solution, 2021- 2031F |
6.2 Netherlands Gemcitabine Hydrochloride Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Gemcitabine Hydrochloride Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 Netherlands Gemcitabine Hydrochloride Market Revenues & Volume, By Non-small Cell Lung Cancer, 2021- 2031F |
6.2.4 Netherlands Gemcitabine Hydrochloride Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F |
6.2.5 Netherlands Gemcitabine Hydrochloride Market Revenues & Volume, By Others, 2021- 2031F |
7 Netherlands Gemcitabine Hydrochloride Market Import-Export Trade Statistics |
7.1 Netherlands Gemcitabine Hydrochloride Market Export to Major Countries |
7.2 Netherlands Gemcitabine Hydrochloride Market Imports from Major Countries |
8 Netherlands Gemcitabine Hydrochloride Market Key Performance Indicators |
8.1 Patient survival rates post gemcitabine hydrochloride treatment |
8.2 Adoption rate of gemcitabine hydrochloride in different cancer types |
8.3 Number of clinical trials and research studies on gemcitabine hydrochloride conducted in the Netherlands |
9 Netherlands Gemcitabine Hydrochloride Market - Opportunity Assessment |
9.1 Netherlands Gemcitabine Hydrochloride Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Netherlands Gemcitabine Hydrochloride Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Netherlands Gemcitabine Hydrochloride Market - Competitive Landscape |
10.1 Netherlands Gemcitabine Hydrochloride Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Gemcitabine Hydrochloride Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here